内脏脂肪指数与高血压患病率的相关性研究：基于美国NHANES 2007~2018年数据
A Study of the Correlation between Visceral Adiposity Index and the Prevalence of Hypertension: A Study Based on US NHANES Data from 2007 to 2018
DOI: 10.12677/acm.2025.152541, PDF,   
作者: 宋佳琪, 车金航, 周若愚, 詹晓丹, 贺 娜, 刘增长*：重庆医科大学第二附属医院心血管内科，重庆；童 瑾：重庆医科大学第二附属医院重症医学科，重庆
关键词: 高血压患病率；NHANES；内脏脂肪指数；内脏脂肪；Hypertension Prevalence； NHANES； Visceral Adiposity Index； Visceral Fat
摘要: 背景：本研究探讨了内脏肥胖指数与美国高血压患病率之间的关系。研究方法：这项横断面研究使用了美国国家健康与营养调查(national health and nutrition examination survey, NHANES)的数据，该调查在2007年至2018年期间连续进行了六次，每次为期两年。研究采用多变量逻辑回归和平滑曲线拟合技术，分别研究了高血压患病率与内脏脂肪指数(visceral adiposity index, VAI)之间的关系。利用亚组分析和交互检验对二者之间关系的稳定性进行了检验。结果：在28,743名参与者中，有12,405人患有高血压，16,338人不患有高血压。在对所有协变量进行调整后，VAI与高血压患病率呈显著正相关[OR = 1.07, 95% CI = 1.06~1.08; P < 0.0001]，并且在将VAI转换为分类变量后仍保持稳定。亚组分析显示，在女性、20~39岁、无糖尿病或吸烟少的参与者中，VAI与高血压患病率之间的相关性更大。结论：VAI分数越高，高血压患病率越高，两者之间似乎存在相关性。减少内脏脂肪可能有助于降低高血压的患病率。
Abstract: Background: This research examined the connection between the visceral obesity index and the prevalence of hypertension in the United States. Methods: This cross-sectional research used data from the National Health and Nutrition Examination Survey (NHANES), conducted in six consecutive two-year cycles between 2007 and 2018. The study employed multivariable logistic regression and smoothing curve fitting techniques to investigate the relationship between the prevalence of hypertension and the visceral adiposity index (VAI), respectively. The stability of the association between them was tested utilizing subgroup analysis and interaction tests. Results: Of the 28,743 participants, 12,405 had hypertension and 16,338 did not. After adjusting for all covariates, VAI was significantly and positively associated with the prevalence of hypertension [odd ratio (OR) = 1.07, 95% confidence interval (CI) 1.06~1.08; P-value < 0.0001] and remained stable after converting VAI to a categorical variable. Subgroup analyses revealed a greater correlation between VAI and the prevalence of hypertension among participants who were female, aged 20~39, without diabetes, or smoked a small number of cigarettes. Conclusions: Higher VAI scores and a greater prevalence of hypertension seem to be correlated. Reducing visceral fat may help reduce the prevalence of hypertension.
文章引用：宋佳琪, 童瑾, 车金航, 周若愚, 詹晓丹, 贺娜, 刘增长. 内脏脂肪指数与高血压患病率的相关性研究：基于美国NHANES 2007~2018年数据[J]. 临床医学进展, 2025, 15(2): 1821-1831. https://doi.org/10.12677/acm.2025.152541

参考文献

[1] Murray, C.J.L., Aravkin, A.Y., Zheng, P., Abbafati, C., Abbas, K.M., Abbasi-Kangevari, M., et al. (2020) Global Burden of 87 Risk Factors in 204 Countries and Territories, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019. The Lancet, 396, 1223-1249. [Google Scholar] [CrossRef] [PubMed]
[2] Zhou, B., Carrillo-Larco, R.M., Danaei, G., Riley, L.M., Paciorek, C.J., Stevens, G.A., et al. (2021) Worldwide Trends in Hypertension Prevalence and Progress in Treatment and Control from 1990 to 2019: A Pooled Analysis of 1201 Population-Representative Studies with 104 Million Participants. The Lancet, 398, 957-980. [Google Scholar] [CrossRef] [PubMed]
[3] Desai, A.N. (2020) High Blood Pressure. Journal of the American Medical Association, 324, 1254-1255. [Google Scholar] [CrossRef] [PubMed]
[4] Fuchs, F.D. and Whelton, P.K. (2020) High Blood Pressure and Cardiovascular Disease. Hypertension, 75, 285-292. [Google Scholar] [CrossRef] [PubMed]
[5] Valenzuela, P.L., Carrera-Bastos, P., Gálvez, B.G., Ruiz-Hurtado, G., Ordovas, J.M., Ruilope, L.M., et al. (2020) Lifestyle Interventions for the Prevention and Treatment of Hypertension. Nature Reviews Cardiology, 18, 251-275. [Google Scholar] [CrossRef] [PubMed]
[6] Ortega, F.B., Lavie, C.J. and Blair, S.N. (2016) Obesity and Cardiovascular Disease. Circulation Research, 118, 1752-1770. [Google Scholar] [CrossRef] [PubMed]
[7] Powell-Wiley, T.M., Poirier, P., Burke, L.E., Després, J., Gordon-Larsen, P., Lavie, C.J., et al. (2021) Obesity and Cardiovascular Disease: A Scientific Statement from the American Heart Association. Circulation, 143, e984-e1010. [Google Scholar] [CrossRef] [PubMed]
[8] Zhu, Q. and Scherer, P.E. (2017) Immunologic and Endocrine Functions of Adipose Tissue: Implications for Kidney Disease. Nature Reviews Nephrology, 14, 105-120. [Google Scholar] [CrossRef] [PubMed]
[9] Tesauro, M., Mascali, A., Franzese, O., Cipriani, S., Cardillo, C. and Di Daniele, N. (2012) Chronic Kidney Disease, Obesity, and Hypertension: The Role of Leptin and Adiponectin. International Journal of Hypertension, 2012, 1-7. [Google Scholar] [CrossRef] [PubMed]
[10] Cildir, G., Akıncılar, S.C. and Tergaonkar, V. (2013) Chronic Adipose Tissue Inflammation: All Immune Cells on the Stage. Trends in Molecular Medicine, 19, 487-500. [Google Scholar] [CrossRef] [PubMed]
[11] Zhang, Z., Zhao, L., Zhou, X., Meng, X. and Zhou, X. (2023) Role of Inflammation, Immunity, and Oxidative Stress in Hypertension: New Insights and Potential Therapeutic Targets. Frontiers in Immunology, 13, Article 1098725. [Google Scholar] [CrossRef] [PubMed]
[12] González-Muniesa, P., Mártinez-González, M., Hu, F.B., Després, J., Matsuzawa, Y., Loos, R.J.F., et al. (2017) Obesity. Nature Reviews Disease Primers, 3, Article No. 17034. [Google Scholar] [CrossRef] [PubMed]
[13] Neeland, I.J., Ross, R., Després, J., Matsuzawa, Y., Yamashita, S., Shai, I., et al. (2019) Visceral and Ectopic Fat, Atherosclerosis, and Cardiometabolic Disease: A Position Statement. The Lancet Diabetes & Endocrinology, 7, 715-725. [Google Scholar] [CrossRef] [PubMed]
[14] Amato, M.C. and Giordano, C. (2014) Visceral Adiposity Index: An Indicator of Adipose Tissue Dysfunction. International Journal of Endocrinology, 2014, 1-7. [Google Scholar] [CrossRef] [PubMed]
[15] Amato, M.C., Giordano, C., Galia, M., Criscimanna, A., Vitabile, S., Midiri, M., et al. (2010) Visceral Adiposity Index. Diabetes Care, 33, 920-922. [Google Scholar] [CrossRef] [PubMed]
[16] Fan, Y., He, D., Liu, S., Qiao, Y., Gao, H. and Xin, L. (2021) Association between Visceral Adipose Index and Risk of Hypertension in a Middle-Aged and Elderly Chinese Population. Nutrition, Metabolism and Cardiovascular Diseases, 31, 2358-2365. [Google Scholar] [CrossRef] [PubMed]
[17] Bagyura, Z., Kiss, L., Lux, Á., Csobay-Novák, C., Jermendy, Á.L., Polgár, L., et al. (2020) Association between Coronary Atherosclerosis and Visceral Adiposity Index. Nutrition, Metabolism and Cardiovascular Diseases, 30, 796-803. [Google Scholar] [CrossRef] [PubMed]
[18] Poulter, N.R., Prabhakaran, D. and Caulfield, M. (2015) Hypertension. The Lancet, 386, 801-812. [Google Scholar] [CrossRef] [PubMed]
[19] Kim, D.D. and Basu, A. (2016) Estimating the Medical Care Costs of Obesity in the United States: Systematic Review, Meta-Analysis, and Empirical Analysis. Value in Health, 19, 602-613. [Google Scholar] [CrossRef] [PubMed]
[20] Brauer, P., Gorber, S.C., Shaw, E., Singh, H., Bell, N., Shane, A.R.E., et al. (2015) Recommendations for Prevention of Weight Gain and Use of Behavioural and Pharmacologic Interventions to Manage Overweight and Obesity in Adults in Primary Care. Canadian Medical Association Journal, 187, 184-195. [Google Scholar] [CrossRef] [PubMed]
[21] Müller, M.J. and Geisler, C. (2017) Defining Obesity as a Disease. European Journal of Clinical Nutrition, 71, 1256-1258. [Google Scholar] [CrossRef] [PubMed]
[22] Neeland, I.J., Ayers, C.R., Rohatgi, A.K., Turer, A.T., Berry, J.D., Das, S.R., et al. (2013) Associations of Visceral and Abdominal Subcutaneous Adipose Tissue with Markers of Cardiac and Metabolic Risk in Obese Adults. Obesity, 21, E439-E447. [Google Scholar] [CrossRef] [PubMed]
[23] Chen, J., Talwalkar, J.A., Yin, M., Glaser, K.J., Sanderson, S.O. and Ehman, R.L. (2011) Early Detection of Nonalcoholic Steatohepatitis in Patients with Nonalcoholic Fatty Liver Disease by Using MR Elastography. Radiology, 259, 749-756. [Google Scholar] [CrossRef] [PubMed]
[24] Brahimaj, A., Rivadeneira, F., Muka, T., Sijbrands, E.J.G., Franco, O.H., Dehghan, A., et al. (2019) Novel Metabolic Indices and Incident Type 2 Diabetes among Women and Men: The Rotterdam Study. Diabetologia, 62, 1581-1590. [Google Scholar] [CrossRef] [PubMed]
[25] Al-Daghri, N.M., Al-Attas, O.S., Wani, K., Alnaami, A.M., Sabico, S., Al-Ajlan, A., et al. (2015) Sensitivity of Various Adiposity Indices in Identifying Cardiometabolic Diseases in Arab Adults. Cardiovascular Diabetology, 14, Article No. 101. [Google Scholar] [CrossRef] [PubMed]
[26] Zhang, Z., Shi, D., Zhang, Q., Wang, S., Liu, K., Meng, Q., et al. (2018) Visceral Adiposity Index (VAI), a Powerful Predictor of Incident Hypertension in Prehypertensives. Internal and Emergency Medicine, 13, 509-516. [Google Scholar] [CrossRef] [PubMed]
[27] Xue, Y., Shen, Q., Li, C., Dai, Z. and He, T. (2020) The Visceral Adipose Index in Relation to Incidence of Hypertension in Chinese Adults: China Health and Nutrition Survey (CHNS). Nutrients, 12, Article 805. [Google Scholar] [CrossRef] [PubMed]
[28] Landsberg, L., Aronne, L.J., Beilin, L.J., Burke, V., Igel, L.I., Lloyd-Jones, D., et al. (2012) Obesity-Related Hypertension: Pathogenesis, Cardiovascular Risk, and Treatment—A Position Paper of the Obesity Society and the American Society of Hypertension. Obesity, 21, 8-24. [Google Scholar] [CrossRef] [PubMed]
[29] Kotchen, T.A. (2010) Obesity-Related Hypertension: Epidemiology, Pathophysiology, and Clinical Management. American Journal of Hypertension, 23, 1170-1178. [Google Scholar] [CrossRef] [PubMed]
[30] Yaribeygi, H., Farrokhi, F.R., Butler, A.E. and Sahebkar, A. (2018) Insulin Resistance: Review of the Underlying Molecular Mechanisms. Journal of Cellular Physiology, 234, 8152-8161. [Google Scholar] [CrossRef] [PubMed]
[31] Hilliard, L.M., Sampson, A.K., Brown, R.D. and Denton, K.M. (2012) The “His and Hers” of the Renin-Angiotensin System. Current Hypertension Reports, 15, 71-79. [Google Scholar] [CrossRef] [PubMed]
[32] Ko, S. and Jung, Y. (2021) Energy Metabolism Changes and Dysregulated Lipid Metabolism in Postmenopausal Women. Nutrients, 13, Article 4556. [Google Scholar] [CrossRef] [PubMed]
[33] Seravalle, G. and Grassi, G. (2017) Obesity and Hypertension. Pharmacological Research, 122, 1-7. [Google Scholar] [CrossRef] [PubMed]
[34] Hall, J.E., da Silva, A.A., do Carmo, J.M., Dubinion, J., Hamza, S., Munusamy, S., et al. (2010) Obesity-Induced Hypertension: Role of Sympathetic Nervous System, Leptin, and Melanocortins. Journal of Biological Chemistry, 285, 17271-17276. [Google Scholar] [CrossRef] [PubMed]
[35] Grassi, G., Seravalle, G., Dell'Oro, R., Trevano, F.Q., Bombelli, M., Scopelliti, F., et al. (2003) Comparative Effects of Candesartan and Hydrochlorothiazide on Blood Pressure, Insulin Sensitivity, and Sympathetic Drive in Obese Hypertensive Individuals. Journal of Hypertension, 21, 1761-1769. [Google Scholar] [CrossRef] [PubMed]
[36] Liu, J., Yang, X., Yu, S. and Zheng, R. (2018) The Leptin Resistance. In: Advances in Experimental Medicine and Biology, Springer, 145-163. [Google Scholar] [CrossRef] [PubMed]

为你推荐